M F Vaezi

Summary

Affiliation: Cleveland Clinic Foundation
Country: USA

Publications

  1. ncbi Quantitative methods to determine efficacy of treatment in achalasia
    M F Vaezi
    Center for Swallowing and Esophageal Disorders, Department of Gastroenterology, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Gastrointest Endosc Clin N Am 11:409-24, viii-ix. 2001
  2. ncbi Extraesophageal manifestations of gastroesophageal reflux disease
    Michael F Vaezi
    Center for Swallowing and Esophageal Disorders, Department of Gastroenterology and Hepatology, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Clin Cornerstone 5:32-8; discussion 39-40. 2003
  3. ncbi Laryngeal signs and symptoms and gastroesophageal reflux disease (GERD): a critical assessment of cause and effect association
    Michael F Vaezi
    Center for Swallowing and Esophageal Disorders, Department of Gastroenterology and Hepatology, A30, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Clin Gastroenterol Hepatol 1:333-44. 2003
  4. ncbi Laryngitis and gastro-oesophageal reflux disease (GERD): improve laryngoscopic specificity, don't do pH monitoring
    M F Vaezi
    Center for Swallowing and Esophageal Disorders, Department of Gastroenterology and Hepatology, A30, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Dig Liver Dis 36:103-4. 2004
  5. ncbi Gastroesophageal reflux disease and the larynx
    Michael F Vaezi
    Center for Swallowing and Esophageal Disorders, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    J Clin Gastroenterol 36:198-203. 2003
  6. ncbi Cost-assessment of alternative management strategies for achalasia
    Marcelo F Vela
    Department of Gastroenterology and Hepatology, Center for Swallowing and Esophageal Disorders, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, Ohio 44195, USA
    Expert Opin Pharmacother 4:2019-25. 2003
  7. ncbi Timed barium oesophagram: better predictor of long term success after pneumatic dilation in achalasia than symptom assessment
    M F Vaezi
    Center for Swallowing and Esophageal Disorders, Department of Gastroenterology, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Gut 50:765-70. 2002
  8. ncbi Review article: the role of pH monitoring in extraoesophageal gastro-oesophageal reflux disease
    M F Vaezi
    Division of Gastroenterology and Hepatology, Center for Swallowing and Esophageal Disorders, Vanderbilt University Medical Center, Nashville, TN, USA
    Aliment Pharmacol Ther 23:40-9. 2006
  9. ncbi Ambulatory gastric pH monitoring: proper probe placement and normal values
    W K Fackler
    Center for Swallowing and Oesophageal Disorders, Cleveland Clinic Foundation, Cleveland, USA
    Aliment Pharmacol Ther 15:1155-62. 2001
  10. ncbi Duodenogastroesophageal reflux and methods to monitor nonacidic reflux
    M F Vaezi
    Center for Swallowing and Esophageal Disorders, Department of Gastroenterology, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Am J Med 111:160S-168S. 2001

Collaborators

Detail Information

Publications51

  1. ncbi Quantitative methods to determine efficacy of treatment in achalasia
    M F Vaezi
    Center for Swallowing and Esophageal Disorders, Department of Gastroenterology, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Gastrointest Endosc Clin N Am 11:409-24, viii-ix. 2001
    ..Recent data suggest that barium esophagram may be most practical and informative compared to manometry and scintigraphy in predicting treatment success in achalasia patients after therapy...
  2. ncbi Extraesophageal manifestations of gastroesophageal reflux disease
    Michael F Vaezi
    Center for Swallowing and Esophageal Disorders, Department of Gastroenterology and Hepatology, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Clin Cornerstone 5:32-8; discussion 39-40. 2003
    ..Response to aggressive acid suppression is often the best indication of GERD etiology in a patient with extraesophageal symptoms...
  3. ncbi Laryngeal signs and symptoms and gastroesophageal reflux disease (GERD): a critical assessment of cause and effect association
    Michael F Vaezi
    Center for Swallowing and Esophageal Disorders, Department of Gastroenterology and Hepatology, A30, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Clin Gastroenterol Hepatol 1:333-44. 2003
    ..In this article we discuss the reasons for this controversy and highlight the recent data attempting to clarify this complex area...
  4. ncbi Laryngitis and gastro-oesophageal reflux disease (GERD): improve laryngoscopic specificity, don't do pH monitoring
    M F Vaezi
    Center for Swallowing and Esophageal Disorders, Department of Gastroenterology and Hepatology, A30, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Dig Liver Dis 36:103-4. 2004
  5. ncbi Gastroesophageal reflux disease and the larynx
    Michael F Vaezi
    Center for Swallowing and Esophageal Disorders, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    J Clin Gastroenterol 36:198-203. 2003
    ..Hence, a multidisciplinary approach is often required in the optimum treatment of these patients...
  6. ncbi Cost-assessment of alternative management strategies for achalasia
    Marcelo F Vela
    Department of Gastroenterology and Hepatology, Center for Swallowing and Esophageal Disorders, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, Ohio 44195, USA
    Expert Opin Pharmacother 4:2019-25. 2003
    ..We are therefore confronted with an increasing demand to justify the value of our therapeutic interventions, not only from the risk/benefit standpoint but also from the cost perspective [6,7]...
  7. ncbi Timed barium oesophagram: better predictor of long term success after pneumatic dilation in achalasia than symptom assessment
    M F Vaezi
    Center for Swallowing and Esophageal Disorders, Department of Gastroenterology, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Gut 50:765-70. 2002
    ..Recently, we showed that symptom relief and objective oesophageal emptying are concordant in about 70% of patients, while up to 30% of achalasia patients report near complete symptom relief despite poor oesophageal emptying of barium...
  8. ncbi Review article: the role of pH monitoring in extraoesophageal gastro-oesophageal reflux disease
    M F Vaezi
    Division of Gastroenterology and Hepatology, Center for Swallowing and Esophageal Disorders, Vanderbilt University Medical Center, Nashville, TN, USA
    Aliment Pharmacol Ther 23:40-9. 2006
    ....
  9. ncbi Ambulatory gastric pH monitoring: proper probe placement and normal values
    W K Fackler
    Center for Swallowing and Oesophageal Disorders, Cleveland Clinic Foundation, Cleveland, USA
    Aliment Pharmacol Ther 15:1155-62. 2001
    ..3%. CONCLUSION: The fundus is the optimal location to evaluate the presence of gastric acid; pH values are highly reproducible in this area. Normal values for percentage time gastric pH < 4 for a healthy population are now defined...
  10. ncbi Duodenogastroesophageal reflux and methods to monitor nonacidic reflux
    M F Vaezi
    Center for Swallowing and Esophageal Disorders, Department of Gastroenterology, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Am J Med 111:160S-168S. 2001
    ..Studies show that this may be accomplished by antireflux surgery or the use of proton pump inhibitors, which by reducing gastric volume, decrease the damaging potential of both acid and DGER...
  11. ncbi Laryngeal disorders in patients with gastroesophageal reflux disease
    F Farrokhi
    Division of Gastroenterology and Hepatology, Center for Swallowing and Esophageal Disorders, Vanderbilt University Medical Center, Nashville, TN, USA
    Minerva Gastroenterol Dietol 53:181-7. 2007
    ..In majority of those who are unresponsive to such therapy other causes of laryngeal irritation is considered. Surgical fundoplication is most effective in those who are responsive to acid suppressive therapy...
  12. ncbi Extra-esophageal manifestations of gastroesophageal reflux
    F Farrokhi
    Division of Gastroenterology and Hepatology, Center for Swallowing and Esophageal Disorders, Vanderbilt University Medical Center, Nashville, Tennessee, USA
    Oral Dis 13:349-59. 2007
    ..However, PPI-unresponsive patients usually have causes other than GERD for the extra-esophageal symptoms and signs...
  13. ncbi New techniques in measuring nonacidic esophageal reflux
    M F Vaezi
    Department of Gastroenterology, The Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    Semin Thorac Cardiovasc Surg 13:255-64. 2001
    ..Future studies in this area, however, will prove beneficial in identifying their role in diagnosis and management of patients with suspected nonacid reflux disease...
  14. ncbi CON: Treatment with PPIs should not be preceded by pH monitoring in patients suspected of laryngeal reflux
    Michael F Vaezi
    Division of Gastroenterology and Hepatology, Center for Swallowing and Esophageal Disorders, Vanderbilt University Medical Center, Nashville, Tennessee, USA
    Am J Gastroenterol 101:8-10. 2006
  15. ncbi Prevalence of laryngeal irritation signs associated with reflux in asymptomatic volunteers: impact of endoscopic technique (rigid vs. flexible laryngoscope)
    Claudio F Milstein
    The Voice Center, Head and Neck Institute, Center for Swallowing and Esophageal Disorders, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Laryngoscope 115:2256-61. 2005
    ....
  16. ncbi Correlation between symptoms and laryngeal signs in laryngopharyngeal reflux
    Mohammed A Qadeer
    Department of Gastroenterology and Hepatology, Center for Swallowing and Esophageal Disorders, Cleveland Clinic Foundation, Cleveland, Ohio, USA
    Laryngoscope 115:1947-52. 2005
    ..In patients unresponsive to twice-daily proton-pump inhibitor therapy for 4 months, further aggressive therapy is unlikely to bring additional symptomatic benefit...
  17. ncbi A physiologic clinical study of achalasia: should Dor fundoplication be added to Heller myotomy?
    Thomas W Rice
    Center for Swallowing and Esophageal Disorders and the Department of Thoracic and Cardiovascular Surgery, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    J Thorac Cardiovasc Surg 130:1593-600. 2005
    ..Therefore, we objectively studied the physiologic effects of adding Dor fundoplication to Heller myotomy...
  18. ncbi Treatment of chronic posterior laryngitis with esomeprazole
    Michael F Vaezi
    Center for Swallowing and Esophageal Disorders, Department of Gastroenterology and Hepatology, Cleveland Clinic Foundation, OH, and the Department of Medicine, Temple University School of Medicine, Philadelphia, PA, USA
    Laryngoscope 116:254-60. 2006
    ..To evaluate the efficacy of acid-suppressive therapy with the proton pump inhibitor esomeprazole on the signs and symptoms of chronic posterior laryngitis (CPL) in patients with suspected reflux laryngitis...
  19. ncbi Chronic laryngitis associated with gastroesophageal reflux: prospective assessment of differences in practice patterns between gastroenterologists and ENT physicians
    Tasneem F Ahmed
    Department of Gastroenterology and Hepatology, Center for Swallowing and Esophageal Disorders, Cleveland Clinic Foundation, Cleveland, OH, USA
    Am J Gastroenterol 101:470-8. 2006
    ..4) Our study highlights a need for cross communication and education between these two disciplines in understanding and treating GERD-related laryngitis better...
  20. ncbi Surgical fundoplication in laryngopharyngeal reflux unresponsive to aggressive acid suppression: a controlled study
    Jason Swoger
    Department of Gastroenterology and Hepatology, Center for Swallowing and Esophageal Disorders, Cleveland Clinic Foundation, Cleveland, Ohio, USA
    Clin Gastroenterol Hepatol 4:433-41. 2006
    ..The argument of low volume or intermittent reflux as the cause of persistent laryngeal symptoms needs to be replaced with evaluation and therapy for other potential non-GERD causes...
  21. ncbi Should we bravo?
    Michael F Vaezi
    Gastroenterology 130:2238-9. 2006
  22. ncbi Proton pump inhibitor therapy for suspected GERD-related chronic laryngitis: a meta-analysis of randomized controlled trials
    Mohammed A Qadeer
    Department of Gastroenterology and Hepatology, Cleveland Clinic Foundation, Cleveland, Ohio, USA
    Am J Gastroenterol 101:2646-54. 2006
    ..Validated diagnostic guidelines may facilitate the recognition of those patients most likely to respond favorably to PPI treatment...
  23. ncbi Are there specific laryngeal signs for gastroesophageal reflux disease?
    Michael F Vaezi
    Am J Gastroenterol 102:723-4. 2007
  24. ncbi Laryngeal manifestations of gastroesophageal reflux disease
    Michael F Vaezi
    Division of Gastroenterology and Hepatology, Center for Swallowing and Esophageal Disorders, Vanderbilt University Medical Center, C2104 MCN, Nashville, TN 37232, USA
    Curr Gastroenterol Rep 10:271-7. 2008
    ..Other causes of laryngeal irritation are considered in most of those who are unresponsive to such therapy. Surgical fundoplication is most effective in those who are responsive to acid-suppressive therapy...
  25. ncbi Sore throat and a red hypopharynx: is it reflux?
    Michael F Vaezi
    Division of Gastroenterology and Hepatology, Center for Swallowing and Esophageal Disorders, Vanderbilt University Medical Center, Nashville, Tennessee, USA
    Clin Gastroenterol Hepatol 5:1379-82. 2007
  26. ncbi Laryngopharyngeal reflux: prospective cohort study evaluating optimal dose of proton-pump inhibitor therapy and pretherapy predictors of response
    Woosuk Park
    Department of Gastroenterology and Hepatology, Center for Swallowing and Esophageal Disorders, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Laryngoscope 115:1230-8. 2005
    ..More response was achieved at 4 months compared with 2 months. Therefore, aggressive acid suppression with BID PPI for at least 4 months is warranted for treatment of LPR...
  27. ncbi Atypical manifestations of gastroesophageal reflux disease
    Michael F Vaezi
    Clinical Research, Vanderbilt University Medical Center, Nashville, Tennessee, USA
    MedGenMed 7:25. 2005
  28. ncbi Dysphagia: a cost analysis of the diagnostic approach
    Tuba Esfandyari
    Department of Gastroenterology, Center for Swallowing and Esophageal Disorders, Cleveland Clinic Foundation, Ohio 44195, USA
    Am J Gastroenterol 97:2733-7. 2002
    ....
  29. ncbi The prevalence of hypopharynx findings associated with gastroesophageal reflux in normal volunteers
    Douglas M Hicks
    The Voice Center, Department of Otolaryngology and Communicative Disorders, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    J Voice 16:564-79. 2002
    ..Intraexaminer and interexaminer agreement information is provided. The traditional attribution of hypopharynx irritation signs to reflux is challenged; the need for improved diagnostic specificity is highlighted...
  30. ncbi Sensitivity and specificity of reflux-attributed laryngeal lesions: experimental and clinical evidence
    Michael F Vaezi
    Center for Swallowing and Esophageal Disorders, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Am J Med 115:97S-104S. 2003
    ..Based on present data, we recommend aggressive acid suppression with twice-daily dosing of proton pump inhibitors for >or=4 months in these patients...
  31. ncbi Laryngitis and gastroesophageal reflux disease: increasing prevalence or poor diagnostic tests?
    Michael F Vaezi
    Am J Gastroenterol 99:786-8. 2004
    ..GERD may be one cause of laryngeal signs and symptoms in a subgroup of patients but not in all those currently so suspected. Future, studies are needed in this area to better delineate this association...
  32. ncbi "Refractory GERD": acid, nonacid, or not GERD?
    Michael F Vaezi
    Am J Gastroenterol 99:989-90. 2004
    ..quot; However, this term is poorly defined and has a different meaning in different countries. More importantly, the cause of "refractory GERD" is poorly understood...
  33. ncbi Therapy Insight: gastroesophageal reflux disease and laryngopharyngeal reflux
    Michael F Vaezi
    Division of Gastroenterology and Hepatology, Vanderbilt University Medical Center, Nashville, TN 37232 5280, USA
    Nat Clin Pract Gastroenterol Hepatol 2:595-603. 2005
    ..This review discusses the reasons for this controversy and highlights data that attempt to clarify this complex area...
  34. ncbi The role of esophageal pH monitoring in symptomatic patients on PPI therapy
    Samer Charbel
    Departments of Gastroenterology and Hepatology, Center for Swallowing and Esophageal Disorders, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Am J Gastroenterol 100:283-9. 2005
    ..01) than those on q.d. PPIs. CONCLUSIONS: 1) The likelihood of an abnormal esophageal pH for symptomatic GERD patients on b.i.d. PPI is very small. 2) In this group of patients failing b.i.d. PPIs causes other than GERD should be sought...
  35. ncbi The role of pH monitoring in extraesophageal gastroesophageal reflux disease
    Tasneem Ahmed
    Department of Gastroenterology and Hepatology, Center for Swallowing and Esophageal Disorders, Cleveland Clinic Foundation, A30, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Gastrointest Endosc Clin N Am 15:319-31. 2005
    ..The clinical utility of pH monitoring in this patient population, however, remains controversial. In this article, the authors examine the role of pH monitoring in laryngitis, asthma, chronic cough, and NCCP...
  36. ncbi American Gastroenterological Association Medical Position Statement on the management of gastroesophageal reflux disease
    Peter J Kahrilas
    Department of Medicine, Gastroenterology Division, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA
    Gastroenterology 135:1383-1391, 1391.e1-5. 2008
  37. ncbi Long-term effect of H2RA therapy on nocturnal gastric acid breakthrough
    William K Fackler
    Center for Swallowing and Esophageal Disorders, Department of Gastroenterology, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Gastroenterology 122:625-32. 2002
    ..Because of H2RA tolerance, there is no difference in acid suppression between PPI twice daily and PPI twice daily + H2RA after 1 week of combination therapy...
  38. ncbi Does diffuse esophageal spasm progress to achalasia? A prospective cohort study
    Sayed Saeid Khatami
    Department of Gastroenterology and Hepatology, Center for Swallowing and Esophageal Disorders, Cleveland Clinic Foundation, Ohio 44195, USA
    Dig Dis Sci 50:1605-10. 2005
    ..1) Progression from DES to achalasia is uncommon. 2) DES patients with low esophageal body amplitude may develop increased simultaneous contractions over time. 3) DES remains an elusive diagnosis clinically and manometrically...
  39. ncbi Idiopathic (primary) achalasia
    Farnoosh Farrokhi
    Division of Gastroenterology and Hepatology, Center for Swallowing and Esophageal Disorders, Vanderbilt University Medical Center, Nashville, Tennessee, USA
    Orphanet J Rare Dis 2:38. 2007
    ..Although it cannot be permanently cured, excellent palliation is available in over 90% of patients...
  40. ncbi Does acid suppressive therapy reduce the risk of laryngeal cancer recurrence?
    Mohammed A Qadeer
    Department of Gastroenterology and Hepatology, Cleveland Clinic Foundation, Ohio, USA
    Laryngoscope 115:1877-81. 2005
    ..Therefore, we conducted this study to identify potential effect of GERD and acid suppressive therapy on recurrences after larynx-preserving therapies...
  41. ncbi Etiology and pathogenesis of achalasia: the current understanding
    Woosuk Park
    Department of Gastroenterology and Hepatology, Center for Swallowing and Esophageal Disorders, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Am J Gastroenterol 100:1404-14. 2005
    ..Further studies are needed to better understand the etiology and pathogenesis of achalasia-such an understanding will be important in developing safe, effective, and possibly curative therapy for achalasia...
  42. ncbi Nocturnal acid breakthrough: clinical significance and correlation with esophageal acid exposure
    Tina M Ours
    Center for Swallowing and Esophageal Disorders, Department of Gastroenterology, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Am J Gastroenterol 98:545-50. 2003
    ..CONCLUSIONS: NAB is an isolated gastric phenomenon that is poorly controlled even with most aggressive acid suppressive therapy. Esophageal acid suppression and symptom control are not dependent on the degree of NAB elimination...
  43. ncbi Esophageal impedance recording: clinical utility and limitations
    Woosuk Park
    Department of Gastroenterology and Hepatology, Center for Swallowing and Esophageal Disorders, The Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    Curr Gastroenterol Rep 7:182-9. 2005
    ..However, continued improvements in the software and increasing studies in different patient populations will aid in overcoming these limitations...
  44. ncbi Laryngeal cancer and gastroesophageal reflux disease: a case-control study
    Michael F Vaezi
    Department of Gastroenterology, Vanderbilt University Medical Center, Nashville, Tenn, USA
    Am J Med 119:768-76. 2006
    ..We aimed to better understand this relationship by conducting a matched case-control study...
  45. ncbi The cost-effectiveness of treatment strategies for achalasia
    Mendel E Singer
    Division of Gastroenterology, Duke University Medical Center, Durham, North Carolina 27710, USA
    Dig Dis Sci 47:1516-25. 2002
    ..Further studies should examine the long-term relapse rates following treatment with Botox and more precisely determine the quality of life of symptomatic achalasia...
  46. ncbi Predictors of outcome of pneumatic dilation in achalasia
    Kaveh Farhoomand
    Department of Gastroenterology and Hepatology, Center for Swallowing and Esophageal Disorders, Cleveland Clinic Foundation, Ohio, USA
    Clin Gastroenterol Hepatol 2:389-94. 2004
    ..CONCLUSIONS: (1) Young men have a greater failure rate with 3.0-cm PD than older men or women in general, and (2) graded PD in this group starting initially with the 3.0-cm balloon is more likely to fail...
  47. ncbi Esophageal manometry: assessment of interpreter consistency
    Devjit S Nayar
    Department of Gastroenterology and Hepatology, Center for Swallowing and Esophageal Disorders, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, Ohio 44195, USA
    Clin Gastroenterol Hepatol 3:218-24. 2005
    ..Given their uncertain clinical implications, we must either redefine them or eliminate them from practice...
  48. ncbi The role of gastric and duodenal agents in laryngeal injury: an experimental canine model
    Talal Adhami
    Department of Gastroenterology and Hepatology, Center for Swallowing and Esophageal Disorders, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Am J Gastroenterol 99:2098-106. 2004
    ..ii) Duodenal agents do not play a significant role in causing laryngeal injury. (iii) Aggressive acid suppression should eliminate the injurious potential of any gastroduodenal refluxate...
  49. ncbi Gastroesophageal reflux and laryngeal cancer: causation or association? A critical review
    Mohammed A Qadeer
    Department of Gastroenterology and Hepatology, Cleveland Clinic Foundation, Cleveland, OH, USA
    Am J Otolaryngol 27:119-28. 2006
    ..In this article, we address the current literature in a critical manner to facilitate the understanding of this subject and evaluate the relationship between gastroesophageal reflux disease and laryngeal carcinoma...
  50. ncbi Is GERD a risk factor for laryngeal cancer?
    Mohammed A Qadeer
    Department of Internal Medicine, Cleveland Clinic Foundation, Case Western Reserve University, Cleveland, Ohio, USA
    Laryngoscope 115:486-91. 2005
    ..To evaluate the overall strength of the association of GERD with laryngeal cancer, we performed meta-analysis of the original studies in literature...
  51. ncbi American Gastroenterological Association Institute technical review on the management of gastroesophageal reflux disease
    Peter J Kahrilas
    Department of Medicine, Gastroenterology Division, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA
    Gastroenterology 135:1392-1413, 1413.e1-5. 2008